The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease (Q46135770)
Jump to navigation
Jump to search
scientific article published on 15 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease |
scientific article published on 15 June 2013 |
Statements
1 reference
The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease (English)
1 reference
1 reference
Diederick E Grobbee
1 reference
Melvin Lafeber
1 reference
Yolanda van der Graaf
1 reference
Hendrik Nathoe
1 reference
Michiel L Bots
1 reference
Frank L J Visseren
1 reference
15 June 2013
1 reference
166
1 reference
2
1 reference
282-289.e1
1 reference
Identifiers
1 reference